Skip to main navigation
Skip to search
Skip to main content
WashU Research Profiles Home
Help & FAQ
Link opens in a new tab
Search content at WashU Research Profiles
Home
Profiles
Research units
Research output
Dyspnea as a prognostic factor in anaplastic thyroid carcinoma
Lauren Tashima
, Ron Mitzner
, Saima Durvesh
, David Goldenberg
Department of Otolaryngology
Institute of Clinical and Translational Sciences (ICTS)
Bursky Center for Human Immunology and Immunotherapy
Siteman Cancer Center
Brain Tumor Center
Research output
:
Contribution to journal
›
Review article
›
peer-review
21
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Dyspnea as a prognostic factor in anaplastic thyroid carcinoma'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Age at Diagnosis
20%
Aggressive Disease
20%
Aggressive Treatment
20%
Anaplastic Thyroid Cancer
100%
Chemotherapy
40%
Curative Intent
20%
Dyspnea
100%
Improved Survival
20%
Independent Prognostic Factor
20%
Long-term Survival
20%
Male-to-female Ratio
20%
Mean Survival Time
20%
Median Survival
20%
Multivariate Analysis
20%
Poor Prognosis
20%
Potential Prognostic Factors
20%
Presentation Time
40%
Prognostic Factors
100%
Radiation Therapy
20%
Retrospective Review
20%
Single Institution
20%
Surgical Intervention
60%
Thyroid Cancer
20%
Tracheotomy
20%
Univariate Analysis
20%
Medicine and Dentistry
Anaplastic Thyroid Carcinoma
100%
Diseases
20%
Dyspnea
100%
Independent Factor
20%
Long Term Survival
20%
Multivariate Analysis
20%
Prognostic Factor
100%
Radiation Therapy
20%
Radiation Treatment
20%
Thyroid Cancer
20%
Tracheotomy
20%
Univariate Analysis
20%
Nursing and Health Professions
Anaplastic Thyroid Carcinoma
100%
Diseases
20%
Dyspnea
100%
Long Term Survival
20%
Multivariate Analysis
20%
Thyroid Cancer
20%
Tracheotomy
20%
Univariate Analysis
20%
Pharmacology, Toxicology and Pharmaceutical Science
Anaplastic Thyroid Carcinoma
100%
Chemotherapy
40%
Diseases
20%
Dyspnea
100%
Long Term Survival
20%
Thyroid Cancer
20%